Statins useful in heart patients with very low LDL

Key points
- People with very low levels of "bad" LDL cholesterol who suffer a heart attack or other severe acute cardiac event may benefit from initiating a statin right after the event, a study shows.
- Moreover, they say their findings potentially extend the results of these studies to patients who have ACS and very low LDL cholesterol levels.
- The findings suggest that patients who present with ACS and very low LDL cholesterol "may still derive benefit from statin therapy," the researchers conclude.
- "It also may mean that the 'goal LDL' concept is outdated as a tool for defining candidacy for statin therapy in this situation," they assert.
People with very low levels of "bad" LDL cholesterol who suffer a heart attack or other severe acute cardiac event may benefit from initiating a statin right after the event, a study shows.
Researchers took a look back at 155 patients hospitalized for an acute cardiac event who had very low LDL cholesterol levels and found that those individuals who were discharged from the hospital on statin therapy were much less likely to die or experience a second heart attack or stroke at six months, compared to those patients who were not discharged on statin therapy.
In the American Journal of Cardiology, Dr. Thomas T. Tsai from the University of Michigan in Ann Arbor and colleagues say their findings are consistent with findings of two other studies, which showed a decrease in cardiac events in subjects with severe acute heart disease (a.k.a., acute coronary syndrome or ACS) who were treated with high-dose statins, regardless of their LDL cholesterol level.
Moreover, they say their findings potentially extend the results of these studies to patients who have ACS and very low LDL cholesterol levels. In the current study, mean LDL levels on admission to the hospital were 63 milligrams per deciliter - well below the current treatment goal of less than 70 milligrams per deciliter in high-risk patients.
The findings suggest that patients who present with ACS and very low LDL cholesterol "may still derive benefit from statin therapy," the researchers conclude.
"It also may mean that the 'goal LDL' concept is outdated as a tool for defining candidacy for statin therapy in this situation," they assert.
The researchers emphasize that these hypothesis-generating findings "need to be confirmed in larger registries and with clinical trials."
SOURCE: American Journal of Cardiology, December 2005.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Heart & Blood Vessels →
NewsOlder heart patients need personalized preventive care
Strategies to prevent heart attack, stroke and other major cardiac events should be individualized for older adults who should play a role in choosing their therapies, according to an American Heart Association…
29 October 2013
NewsStudy shows no increased risk for heart attacks among HIV-positive patients with high CD4 cell count
Patients who are HIV-positive and have high CD4 cell counts — or have a high number of white blood cells that fight infections - aren't at an increased risk for heart attacks compared to patients who are HIV-negative,…
25 October 2013
NewsHeart attack patients return to work later and retire earlier if treatment is delayed
System delay in treating patients with ST-elevation myocardial infarction (STEMI) postpones their return to work and increases early retirement, according to research presented at the Acute Cardiac Care Congress 2013 by…




